IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 51 filers reported holding IGM BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,258 | -15.7% | 15,480 | -6.8% | 0.00% | – |
| Q2 2023 | $153,282 | -28.2% | 16,607 | +6.9% | 0.00% | – |
| Q1 2023 | $213,355 | -30.2% | 15,528 | -13.6% | 0.00% | – |
| Q4 2022 | $305,739 | +70.8% | 17,974 | +128.3% | 0.00% | – |
| Q3 2022 | $179,000 | +43.2% | 7,873 | +13.3% | 0.00% | – |
| Q2 2022 | $125,000 | +13.6% | 6,950 | +69.0% | 0.00% | – |
| Q1 2022 | $110,000 | -76.6% | 4,113 | -74.3% | 0.00% | – |
| Q4 2021 | $470,000 | +95.8% | 16,035 | +339.7% | 0.00% | – |
| Q3 2021 | $240,000 | -4.4% | 3,647 | +20.7% | 0.00% | – |
| Q2 2021 | $251,000 | +3.7% | 3,021 | -4.2% | 0.00% | – |
| Q1 2021 | $242,000 | -37.0% | 3,154 | -27.5% | 0.00% | – |
| Q4 2020 | $384,000 | +23.1% | 4,348 | +2.7% | 0.00% | – |
| Q3 2020 | $312,000 | +10.6% | 4,233 | +9.8% | 0.00% | – |
| Q2 2020 | $282,000 | +98.6% | 3,856 | +52.2% | 0.00% | – |
| Q1 2020 | $142,000 | +389.7% | 2,534 | +225.7% | 0.00% | – |
| Q4 2019 | $29,000 | – | 778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |